4
Changes in Ownership
Perspective Therapeutics, Inc. Filed Acc 0001437749-17-019783
Controller/Prin Fin&Acct Offic bought 9,265 shares at an average $0.48 ($4,490)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Austin Mark John Controller/Prin Fin&Acct Offic | 2017-11-21 | Purchase | +2,000 | $0.47 | $942 | 2,000 | D: show line 1 in the form |
| Austin Mark John Controller/Prin Fin&Acct Offic | 2017-11-21 | Purchase | +3,400 | $0.49 | $1,649 | 5,400 | D: show line 2 in the form |
| Austin Mark John Controller/Prin Fin&Acct Offic | 2017-11-22 | Purchase | +1,825 | $0.49 | $894 | 7,225 | D: show line 3 in the form |
| Austin Mark John Controller/Prin Fin&Acct Offic | 2017-11-24 | Purchase | +500 | $0.50 | $248 | 7,725 | D: show line 4 in the form |
| Austin Mark John Controller/Prin Fin&Acct Offic | 2017-11-24 | Purchase | +515 | $0.50 | $255 | 8,240 | D: show line 5 in the form |
| Austin Mark John Controller/Prin Fin&Acct Offic | 2017-11-24 | Purchase | +1,025 | $0.49 | $502 | 9,265 | D: show line 6 in the form |
| Open-market purchases · 9,265 sh · avg $0.48 · $4,490 | |||||||
Loading xslF345X03/rdgdoc.xml…